Poly(D,L-lactide-co-glycolide), ester terminated, Mw 50000-75000

Basic Information Description Application Features And Benefits

Catalog Number	ACMA00040457
Synonyms	PLGA
Molecular Weight	Mw 50,000-75,000
Molecular Formula	[C3H4O2]x[C2H2O2]y
Canonical SMILES	OCC(O)=O.CC(O)C(O)=O
Form	amorphous
MDL Number	MFCD00131930
NACRES	NA.23
Packaging	1, 5 g in glass bottle
PubChem ID	24866924
Quality Level	100
Storage Temperature	2-8°C

Description Characteristic properties of ester terminated poly(D,L-lactide-co-glycolide) (PLGA) are in vivo biodegradability, tunable drug release profile and very high encapsulation capacity.

Application PLGA polymers find uses in the production of biodegradable medical sutures and for controlled drug release. PLGA microspheres have been reported for use in controlled release of human growth hormone. Thin membranes of blended polymers constituting of PLGA/polycaprolactone/β-tricalcium phosphate have been used in guided bone regeneration.

Features And Benefits Features and Benefits
Controlled release of bioactive agents, sutures and bioabsorbable implantable devices.

Our products and services are for research use only and cannot be used for any clinical purpose.

The Following May Also Be of Interest to You

• 

  N-Hydroxysuccinimide ester-poly(ethylene glycol)-b-poly(D,L lactide)

  Cat.No. ACMA00040454

• 

  N-Hydroxysuccinimide ester-poly(ethylene glycol)-b-poly(ε-caprolactone)

  Cat.No. ACMA00040455

• 

  Poly(D,L-lactide-co-glycolide), acid terminated, lactide:glycolide 50:50

  Cat.No. ACMA00040456

• 

  Poly(D,L-Lactide-co-Glycolide), lactide:glycolide 50:50, ester terminated

  Cat.No. ACMA00040458

• 

  Poly(D,L-lactide-co-glycolide), lactide:glycolide 65:35, Mw 40000-75000

  Cat.No. ACMA00040459

• 

  Poly(D,L-lactide-co-glycolide), Mn 25000

  Cat.No. ACMA00040460